Nephropathic patients show higher levels of advanced glycation end products (AGEs) and oxidized human serum albumin (HSAox) compared to healthy subjects. These two classes of compounds are formed as the result of oxidative insults; for this reason, they can be useful oxidative stress biomarkers. The present study examines the variation of AGEs and HSAox in hemodialysis (HD) patients before and after dialysis session, evaluating the impact of different dialytic techniques and filters on their removal.
Noce, A., Rovella, V., Marrone, G., Cattani, G., Zingaretti, V., Limongi, D., et al. (2019). Hemodialysis biomarkers: total advanced glycation end products (AGEs) against oxidized human serum albumin (HSAox). ACTA DIABETOLOGICA, 56(12), 1323-1331 [10.1007/s00592-019-01413-7].
Hemodialysis biomarkers: total advanced glycation end products (AGEs) against oxidized human serum albumin (HSAox)
Noce A.;Rovella V.;Limongi D.;D'Agostini C.;Sorge R.;Di Daniele N.;Ricci G.;Bocedi A.
2019-12-01
Abstract
Nephropathic patients show higher levels of advanced glycation end products (AGEs) and oxidized human serum albumin (HSAox) compared to healthy subjects. These two classes of compounds are formed as the result of oxidative insults; for this reason, they can be useful oxidative stress biomarkers. The present study examines the variation of AGEs and HSAox in hemodialysis (HD) patients before and after dialysis session, evaluating the impact of different dialytic techniques and filters on their removal.| File | Dimensione | Formato | |
|---|---|---|---|
|
Noce et al Acta Diabetol 2019.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
1.04 MB
Formato
Adobe PDF
|
1.04 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
